Cited by 1,361Advanced Drug Delivery SystemsNanoparticle-Based Drug DeliveryRNA Interference and Gene Delivery

The DOI matches its Crossref record; 269 of the 275 references it cites were found in a registry or an index.

The evolution of commercial drug delivery technologies

Vargason, Ava M., Anselmo, Aaron C., Mitragotri, Samir·2021·Nature Biomedical Engineering

Open this paper in CoChat — free account

Abstract

Drug delivery technologies have enabled the development of many pharmaceutical products that improve patient health by enhancing the delivery of a therapeutic to its target site, minimizing off-target accumulation and facilitating patient compliance. As therapeutic modalities expanded beyond small molecules to include nucleic acids, peptides, proteins and antibodies, drug delivery technologies were adapted to address the challenges that emerged. In this Review Article, we discuss seminal approaches that led to the development of successful therapeutic products involving small molecules and macromolecules, identify three drug delivery paradigms that form the basis of contemporary drug delivery and discuss how they have aided the initial clinical successes of each class of therapeutic. We also outline how the paradigms will contribute to the delivery of live-cell therapies.

Integrity signals

Registry

Crossref · 10.1038/s41551-021-00698-w

Cites

269 of 269 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Polack, F. P., Thomas, S. J., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Perez, J. L., Pérez Marc, G., Moreira, E. D., Zerbini, C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2034577 · Cited by 14,592
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,484
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
Baden, L. R., El Sahly, H. M., Essink, B., Kotloff, K., Frey, S., Novak, R., Diemert, D., Spector, S. A., Rouphael, N., Creech, C. B., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2035389 · Cited by 10,119
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
Stimuli-responsive nanocarriers for drug delivery
Mura, S., Nicolas, J., & Couvreur, P. (2013) · Nature Materials · doi:10.1038/nmat3776 · Cited by 6,289
Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia
Maude, S. L., Laetsch, T. W., Buechner, J., Rives, S., Boyer, M., Bittencourt, H., Bader, P., Verneris, M. R., Stefanski, H. E., Myers, G. D., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1709866 · Cited by 5,735
Liposomal drug delivery systems: From concept to clinical applications
Allen, T. M., & Cullis, P. R. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.037 · Cited by 4,839
Doxil® — The first FDA-approved nano-drug: Lessons learned
Barenholz, Y. (. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.020 · Cited by 4,792
Drug Delivery Systems: Entering the Mainstream
Allen, T. M., & Cullis, P. R. (2004) · Science · doi:10.1126/science.1095833 · Cited by 4,552

Show all 275 references

Research works printed but not linked: 2

Dost, F. H. Der Blutspiegel: Kinetik der Konzentrationsabläufe in der Kreislaufflüssigkeit (Georg Thieme, 1953).
DeLoach, J. R. & Sprandel, U. (eds) in Bibliotheca Haematologica Vol. 51 (Karger, 1985).

Sorted by citations

Items 301–400 of 1,000

Pharmacokinetics and pharmacodynamics of cyclodextrin-based oral drug delivery formulations for disease therapy
Liu, H., Guo, S., Wei, S., Liu, J., & Tian, B. (2024) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2023.121763 · Cited by 28
Self-Adaptive Nanocarriers Overcome Multiple Physiological Barriers to Boosting Chemotherapy of Orthotopic Pancreatic Cancer
Ding, M., Zong, Q., Zhang, D., Ullah, I., Zhang, X., Liang, W., Li, X., Bulatov, E., & Yuan, Y. (2024) · ACS Nano · doi:10.1021/acsnano.4c11514 · Cited by 28
Transforming the landscape of cancer treatment with seven promising novel therapies: evolution and future perspectives
Miao, H., Yuan, F., Pan, C.-X., Yang, H., Wang, Z., Qi, Y., Wu, Y. Z., Zhang, Y., Liu, F., Huang, H., et al. (2025) · Medicine Plus · doi:10.1016/j.medp.2025.100087 · Cited by 33
Engineering the biophysical properties of lipid nanostructures for drug delivery
Menge, J., Yang, C., Weitz, D. A., & Jahnke, K. (2026) · Communications Materials · doi:10.1038/s43246-026-01073-5 · Cited by 30
α-Mangostin Nanoparticles Cytotoxicity and Cell Death Modalities in Breast Cancer Cell Lines
Herdiana, Y., Wathoni, N., Shamsuddin, S., & Muchtaridi, M. (2021) · Molecules · doi:10.3390/molecules26175119 · Cited by 33
Programmed biomolecule delivery orchestrate bone tissue regeneration via MSC recruitment and epigenetic modulation
Wan, Z., Dong, Q., Liu, Y., Zhang, X., Zhang, P., Lv, L., & Zhou, Y. (2022) · Chemical Engineering Journal · doi:10.1016/j.cej.2022.135518 · Cited by 28
Ibuprofen-Loaded ZnO Nanoparticle/Polyacrylonitrile Nanofibers for Dual-Stimulus Sustained Release of Drugs
Chao, S., Zhang, Y., Cheng, S., Shao, X., Liu, S., Lu, W., Wang, Y., Zhang, P., & Yao, Q. (2023) · ACS Applied Nano Materials · doi:10.1021/acsanm.3c00022 · Cited by 28
Sponge-like macroporous cyclodextrin-based cryogels for controlled drug delivery
Zagni, C., Coco, A., Mecca, T., Curcuruto, G., Patamia, V., Mangano, K., Rescifina, A., & Carroccio, S. C. (2023) · Materials Chemistry Frontiers · doi:10.1039/d3qm00139c · Cited by 29
Protein Nanotubes as Advanced Material Platforms and Delivery Systems
Liu, B., Li, X., Zhang, J. P., Li, X., Yu, Y., Hou, G. H., Zhang, H. J., Zhang, H., Li, Y., & Mezzenga, R. (2023) · Advanced Materials · doi:10.1002/adma.202307627 · Cited by 29
Advancements in therapeutic development: kidney organoids and organs on a chip
Tabibzadeh, N., & Morizane, R. (2024) · Kidney International · doi:10.1016/j.kint.2023.11.035 · Cited by 27
Graphene Quantum Dots (GQD)-Mediated dsRNA Delivery for the Control of Fusarium Head Blight Disease in Wheat
Gyawali, B., Rahimi, R., Alizadeh, H., & Mohammadi, M. (2024) · ACS Applied Bio Materials · doi:10.1021/acsabm.3c00972 · Cited by 29
Small molecules targeting microRNAs: new opportunities and challenges in precision cancer therapy
Jurj, A. M., Fontana, B., Varani, G., & Călin, G. A. (2024) · Trends in cancer · doi:10.1016/j.trecan.2024.06.006 · Cited by 27
Physical, biochemical, and biological characterization of olive-derived lipid nanovesicles for drug delivery applications
Zhao, Z., Lacombe, J., Simon, L., Sanchez‐Ballester, N. M., Khanishayan, A., Shaik, N., Case, K., Dugas, P., Repellin, M., Lollo, G., et al. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02964-w · Cited by 27
“These have been utilized to improve the pharmacokinetic and pharmacodynamic of different classes of therapeutics [2, 3].”
The versatility of peptide hydrogels: From self‐assembly to drug delivery applications
Heremans, J., Ballet, S., & Martin, C. (2024) · Journal of Peptide Science · doi:10.1002/psc.3662 · Cited by 28
“1,35,39 Many pharmaceuticals are characterized by non-optimal properties, such as a low solubility, low stability, and short half-life, necessitating an optimal delivery strategy.”
Influential
Photothermal nanofiber-mediated photoporation for gentle and efficient intracellular delivery of macromolecules
Miao, D., Song, Y., Munter, S. D., Xiao, H., Vandekerckhove, B., Smedt, S. C. D., Huang, C., Braeckmans, K., & Xiong, R. (2025) · Nature Protocols · doi:10.1038/s41596-024-01115-7 · Cited by 27
Sensitized mast cells for targeted drug delivery and augmented cancer immunotherapy
Xu, Y., Zhang, X., Han, X., Huang, H., Meng, C., Yang, Y., Sheng, T., Ren, E., Shi, J., He, K., et al. (2025) · Cell · doi:10.1016/j.cell.2025.11.015 · Cited by 28
Dynamic nanoassemblies for imaging and therapy of neurological disorders
Zhang, L., Sun, H., Zhao, J., Lee, J., Low, L. E., Gong, L., Chen, Y., Wang, N., Zhu, C., Lin, P., et al. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113832 · Cited by 27
Rational Design of a Modality‐Specific Inhibitor of TRPM8 Channel against Oxaliplatin‐Induced Cold Allodynia
Aierken, A., Xie, Y., Dong, W., Apaer, A., Lin, J., Zhao, Z., Yang, S., Xu, Z., & Yang, F. (2021) · Advanced Science · doi:10.1002/advs.202101717 · Cited by 27
Oral Delivery of Nucleic Acid Therapies for Local and Systemic Action
Kumari, N., Siddhanta, K., Panja, S., Joshi, V., Jogdeo, C. M., Kapoor, E., Khan, R. I., Kollala, S. S., Kumar, B., Sil, D., et al. (2022) · Pharmaceutical Research · doi:10.1007/s11095-022-03415-7 · Cited by 28
“Hence, 60% of the small molecules, that make up to 90% of the total commercial drug products, are administered orally [3, 4].”
BackgroundInfluential
Diverse drug delivery systems for the enhancement of cancer immunotherapy: an overview
Liu, X., Cheng, Y., Mu, Y., Zhang, Z., Tian, D., Liu, Y., Hu, X., & Wen, T. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1328145 · Cited by 29
“There are many types of cells that can be used for cellular delivery, including red blood cells, platelets, stem cells, immune cells, and others (214, 215).”
Background
Blueprints for Better Drugs: The Structural Revolution in Nanomedicine
Mirkin, C. A., Langer, R., Mrksich, M., Margolin, A. A., Petrosko, S. H., & Artzi, N. (2025) · ACS Nano · doi:10.1021/acsnano.5c06380 · Cited by 28
Stimuli‐Responsive Aptamer‐Drug Conjugates for Targeted Drug Delivery and Controlled Drug Release
Zhu, S., Gao, H., Li, W., He, X., Jiang, P., Xu, F., Jin, G., & Guo, H. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202401020 · Cited by 26
New insights into the mechanism of resistance to lenvatinib and strategies for lenvatinib sensitization in hepatocellular carcinoma
Fan, F., Fleishman, J. S., Jin, C., Chen, Z., & Dong, H. (2024) · Drug Discovery Today · doi:10.1016/j.drudis.2024.104069 · Cited by 26
Advanced Noninvasive Strategies for the Brain Delivery of Therapeutic Proteins and Peptides
Lin, J., Yu, Z., & Gao, X. (2024) · ACS Nano · doi:10.1021/acsnano.4c06851 · Cited by 28
Landscape of Subcutaneous Administration Strategies for Monoclonal Antibodies in Oncology
Jacquot, G., Navarro, P. L., Grange, C., Boudali, L., Harlepp, S., Pivot, X. B., & Detappe, A. (2024) · Advanced Materials · doi:10.1002/adma.202406604 · Cited by 26
Dual-Ligand Assisted Anisotropic Assembly for the Construction of NIR-II Light-Propelled Mesoporous Nanomotors
Jia, J., Lin, R., Liu, M., Hou, M., Yu, H., Lu, Q., Ma, Y., Zhao, T., Zhang, F., Mady, M. F., et al. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.4c14011 · Cited by 26
Microneedles with an anisotropic porous microstructure facilitate the transdermal delivery of small molecules, lipid nanoparticles, and T cells
Hu, T., Lui, K. S., Ko, E. B., Zhao, Y., Zhang, Q., Yang, H., Zheng, M., Chang, H., Guo, B., Cheung, A. K. L., et al. (2025) · Matter · doi:10.1016/j.matt.2025.102038 · Cited by 26
Integrating Proteolysis‐Targeting Chimeras (PROTACs) with Delivery Systems for More Efficient and Precise Targeted Protein Degradation
Lin, J., Chen, Z., Zhang, D., Zhang, N., Chen, H., & Guo, D. (2025) · Macromolecular Rapid Communications · doi:10.1002/marc.202401051 · Cited by 28
Safety, Stability, and Therapeutic Efficacy of Long-Circulating TQ-Incorporated Liposomes: Implication in the Treatment of Lung Cancer
Khan, A., Alsahli, M. A., Aljasir, M. A., Maswadeh, H., Mobark, M. A., Azam, F., Allemailem, K. S., Alrumaihi, F., Alhumaydhi, F. A., Alwashmi, A. S. S., et al. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14010153 · Cited by 26
Advances in biomaterials for the treatment of retinoblastoma
Farhat, W., Yeung, V., Ross, A., Kahale, F., Boychev, N., Kuang, L., Chen, L., & Ciolino, J. B. (2022) · Biomaterials Science · doi:10.1039/d2bm01005d · Cited by 26
Smart chemistry for traceless release of anticancer therapeutics
Prange, C. J., Hu, X., & Tang, L. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122353 · Cited by 26
Approved delivery strategies for biopharmaceuticals
Zoulikha, M., Chen, Z., Wu, J., & He, W. (2024) · Chinese Chemical Letters · doi:10.1016/j.cclet.2024.110225 · Cited by 26
Designer Solvents for Pharmaceutics: Role of Ionic Liquids/ Deep Eutectic Solvents in Pharmaceutical Formulations
Dhiman, D., Alhammadi, M., Kim, H., Umapathi, R., Huh, Y. S., & Venkatesu, P. (2024) · Advanced Therapeutics · doi:10.1002/adtp.202400090 · Cited by 25
Critical Challenges of Intravenous Nanomaterials Crossing the Blood‐Brain Barrier: from Blood to Brain
Luo, W., Chen, C., Guo, X., Guo, X., Zheng, J., Liu, J., Fan, X., Luo, M., Yu, Z., Li, H., et al. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202409522 · Cited by 27
Functionalization of polymers for intracellular protein delivery
Zhang, Y., Shi, J., Ma, B., Zhou, Y., Yong, H., Li, J., Kong, X., & Zhou, D. (2023) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2023.101751 · Cited by 25
Obesity wars: hypothalamic sEVs a new hope
Mukherjee, S., Diéguez, C., Fernø, J., & López, M. (2023) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2023.04.006 · Cited by 24
Polyethylene Glycol–Based Polymer-Drug Conjugates: Novel Design and Synthesis Strategies for Enhanced Therapeutic Efficacy and Targeted Drug Delivery
Verma, V. S., Pandey, A., Jha, A. K., Badwaik, H. R., Alexander, A., & Ajazuddin, M. (2024) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-024-04895-6 · Cited by 30
Thermosensitive gel-nano system against esophageal cancer via restoring p53 activity and boosting T-cell immunity
Gong, K., Lin, J., Chen, X., Duan, Y., Zhang, J., Yu, J., Wang, J., Sun, R., Li, J., & Duan, Y. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.05.040 · Cited by 24
Multi‐Organ Microphysiological Systems Targeting Specific Organs for Recapitulating Disease Phenotypes via Organ Crosstalk
Kim, J. J., Bae, M., & Cho, D. (2024) · Small Science · doi:10.1002/smsc.202400314 · Cited by 24
Molecular Trojan Based on Membrane‐Mimicking Conjugated Electrolyte for Stimuli‐Responsive Drug Release
Meng, Y. B., Gao, J., Huang, X., Liu, P., Zhang, C., Zhou, P., Bai, Y., Guo, J., Zhou, C. Y., Li, K., et al. (2025) · Advanced Materials · doi:10.1002/adma.202415705 · Cited by 24
Hybrid-designed metal-phenolic nanoparticles for synergistic nano-gene periodontal therapy
Li, D., Wu, Q., Long, C., Yi, P., Wang, S., Wang, Q., & Teng, W. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123417 · Cited by 24
Aggregation-induced emission in natural product research: Recent advances and future perspectives
Fan, W., Li, Z., Chen, K., Wang, Z., & Li, Y. (2025) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2025.216843 · Cited by 24
Achievements and Trends in Biocatalytic Synthesis of Specialty Polymers from Biomass-Derived Monomers Using Lipases
Todea, A., Dreavă, D. M., Benea, I. C., Bîtcan, I., Péter, F., & Boeriu, C. G. (2021) · Processes · doi:10.3390/pr9040646 · Cited by 27
Self-Reporting Polysaccharide Polymersome for Doxorubicin and Cisplatin Delivery to Live Cancer Cells
Virmani, M., Deshpande, N. U., Pathan, S., & Jayakannan, M. (2021) · ACS Polymers Au · doi:10.1021/acspolymersau.1c00042 · Cited by 24
Strategy for Avoiding Protein Corona Inhibition of Targeted Drug Delivery by Linking Recombinant Affibody Scaffold to Magnetosomes
Ma, S., Gu, C., Xu, J., He, J., Li, S., Zheng, H., Pang, B., Wen, Y., Fang, Q., Liu, W., et al. (2022) · International Journal of Nanomedicine · doi:10.2147/ijn.s338349 · Cited by 26
Emerging insights of peptide-based nanotherapeutics for effective management of rheumatoid arthritis
Pathade, V., Nene, S., Ratnam, S., Khatri, D. K., Raghuvanshi, R. S., Singh, S. B., & Srivastava, S. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121257 · Cited by 24
N -Acetylation of Biodegradable Supramolecular Peptide Nanofilaments Selectively Enhances Their Proteolytic Stability for Targeted Delivery of Gold-Based Anticancer Agents
Marciano, Y., Nayeem, N., Dave, D. R., Ulijn, R. V., & Contel, M. (2023) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.3c00312 · Cited by 24
Unraveling the potential of M13 phages in biomedicine: Advancing drug nanodelivery and gene therapy
Fadaie, M., Dianat‐Moghadam, H., Ghafouri, E., Naderi, S., Darvishali, M. H., Ghovvati, M., Khanahmad, H., Boshtam, M., & Makvandi, P. (2023) · Environmental Research · doi:10.1016/j.envres.2023.117132 · Cited by 29
Recent progress in lactate oxidase-based drug delivery systems for enhanced cancer therapy
Li, L., Yue, T., Feng, J., Zhang, Y., Hou, J., & Wang, Y. (2024) · Nanoscale · doi:10.1039/d3nr05952a · Cited by 23
Photoclick surface modification of MOF-808 for galactose-mediated targeted chemotherapy
Wang, Y., Foulkes, R., Panagiotou, N., Markopoulou, P., Popov, A. B., Eskandari, A., Fruk, L., & Forgan, R. S. (2024) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2024.11.129 · Cited by 23
“Targeted nanoparticulate drug delivery systems (DDSs) [1,2] are a rapidly advancing field in nanomedicine, especially cancer treatment [3 – 5].”
T Lymphocyte-Macrophage Hybrid Membrane-Coated Biomimetic Nanoparticles Alleviate Myocarditis via Suppressing Pyroptosis by Targeting Gene Silencing
Xiong, Y., Zhang, Z., Liu, S., Shen, L., Zheng, L., Ding, L., Liu, L., Wu, L., Hu, Z., Li, L., et al. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s487598 · Cited by 24
“8 Consequently, there is an imperative demand for refined strategies that ensure precise targeting and localized intervention.”
Advanced Nanomedicine Delivery Systems for Cardiovascular Diseases: Viral and Non-Viral Strategies in Targeted Therapy
Chen, Q., Yu, T., Gong, J., & Shan, H. (2025) · Molecules · doi:10.3390/molecules30040962 · Cited by 24
“However, the clinical translation of DDSs faces challenges including complex design requirements, low success rates in preclinical models, and long development timelines [10,11].”
Recent Advances in Biomolecule‐Engineered Metal‐Organic Frameworks (Bio‐MOFs): From Design, Bioengineering, and Structural/functional Regulation to Biocatalytic Applications
Du, C., Xu, Y., & Wei, G. (2025) · The Chemical Record · doi:10.1002/tcr.202500001 · Cited by 23
Key Points in Remote-Controlled Drug Delivery: From the Carrier Design to Clinical Trials
Voronin, D. V., Abalymov, A. A., Svenskaya, Y. I., & Lomova, M. V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179149 · Cited by 26
Iron ion-coordinated carrier-free supramolecular co-nanoassemblies of dual DNA topoisomerase-targeting inhibitors for tumor suppression
Guan, J., Tan, X., Jiao, J., Lai, S., Zhang, H., Kan, Q., He, Z., Sun, M., & Sun, J. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.03.027 · Cited by 23
Organic and inorganic nanomedicine for combination cancer therapies
Lee, D., Shin, J., Son, H., Cheon, S. Y., Lee, Y., Park, J., & Koo, H. (2023) · Nanoscale Advances · doi:10.1039/d3na00043e · Cited by 23
Current status and prospects for improved targeted delivery approaches for cancer
Mansouri, S., Alharbi, Y., & Alqahtani, A. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154993 · Cited by 25
Poly( l -alanine- co - l -threonine succinate) as a Biomimetic Cryoprotectant
Park, J. K., Park, S., & Jeong, B. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c11260 · Cited by 23
Strategies for utilizing covalent organic frameworks as host materials for the integration and delivery of bioactives
He, L., Wang, L., He, Z., Pang, C. H., Tang, B., Wu, A., & Li, J. (2023) · Materials Horizons · doi:10.1039/d3mh01492d · Cited by 23
Metabolic model predictions enable targeted microbiome manipulation through precision prebiotics
Μαρίνος, Γ., Hamerich, I. K., Debray, R., Obeng, N., Petersen, C., Taubenheim, J., Zimmermann, J., Blackburn, D., Samuel, B. S., Dierking, K., et al. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.01144-23 · Cited by 23
“From the host side, to maintain relatively constant concentrations in the host environment or to deviate from its normal concentrations, advanced formulations such as nanotechnology (70), delayed release, and other drug delivery technologies (71, 72) could be employed.”
From Conventional to Cutting-edge: A Comprehensive Review on Drug Delivery Systems
Vikal, A., Maurya, R., Bhowmik, S., Patel, P., Gupta, G. D., & Kurmi, B. D. (2024) · Drug Delivery Letters · doi:10.2174/0122103031304556240430161553 · Cited by 24
The Potential Use of Exosomes in Anti-Cancer Effect Induced by Polarized Macrophages
Abe, C., Bhaswant, M., Miyazawa, T., & Miyazawa, T. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15031024 · Cited by 22
“Since the last decade, researchers have provided a lot of solutions such as drug modifications and environmental modifications, and developed drug delivery systems [5,6].”
Background
Targeting lipid metabolism via nanomedicine: A prospective strategy for cancer therapy
Huang, X., Hou, S., Li, Y., Xu, G., Xia, N., Duan, Z., Luo, K., & Tian, B. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.123022 · Cited by 23
Cell-Based Drug Delivery Systems: Innovative Drug Transporters for Targeted Therapy
Sergazy, S. D., Berikkhanova, K., Gulyayev, A., Shulgau, Z., Maikenova, A., Bilal, R., Terzić, M., Zhumadilov, Z. S., & Aljofan, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178143 · Cited by 23
“Living leukocytes offer the advantage of preserving their native membrane structures, maintaining biological activity, and enabling autonomous navigation across biological barriers [75].”
Modulating tumor collagen fiber alignment for enhanced lung cancer immunotherapy via inhaled RNA
Hu, B., Stewart, W., Chen, Q., Zhang, C., Liu, Z., Xu, X., & Zhang, X. (2025) · Nature Communications · doi:10.1038/s41467-025-63415-0 · Cited by 26
Experimental and Theoretical Insights on Chemopreventive Effect of the Liposomal Thymoquinone Against Benzo[a]pyrene-Induced Lung Cancer in Swiss Albino Mice
Khan, A., Alsahli, M. A., Aljasir, M. A., Maswadeh, H., Mobark, M. A., Azam, F., Allemailem, K. S., Alrumaihi, F., Alhumaydhi, F. A., Almatroudi, A. A., et al. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s358632 · Cited by 22
Combined microfluidics and drying processes for the continuous production of micro-/nanoparticles for drug delivery: a review
Patil, A., Patil, P. B., Pardeshi, S. R., Shrimal, P., Rebello, N. L., Mohite, P. B., Chatterjee, A., MUJUMDAR, A. S., & Naik, J. (2023) · Drying Technology · doi:10.1080/07373937.2023.2167827 · Cited by 22
“Drug delivery technology has become vital for reducing harmful side effects and achieving the best outcomes.([88]) Among the many more application related to drug delivery, the most common is the accumulation of the drug in the site of action.”
Background
Triphenylphosphonium conjugated gold nanotriangles impact Pi3K/AKT pathway in breast cancer cells: a photodynamic therapy approach
Vinita, N. M., Umapathy, D., Durgadevi, S., Selvaraj, A., Prabhu, D., Sundarraj, R., Govarthanan, M., Yuvaraj, A., Biruntha, M., Arockiam, A. J. V., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-28678-x · Cited by 22
Glioblastoma-Derived Small Extracellular Vesicles: Nanoparticles for Glioma Treatment
Araujo‐Abad, S., Manresa-Manresa, A., Rodríguez-Cañas, E., Fuentes-Baile, M., García-Morales, P., Mallavia, R. M., Saceda, M., & Romero, C. D. J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065910 · Cited by 23
“Of note, while there are an increasing number of drug delivery systems that are currently being developed and tested in preclinical studies, only a few of them advance to clinical testing due to inherent limitations, such as toxicity to normal cells [44].”
Background
Microalgae-based drug delivery systems in biomedical applications
Huang, H., Lang, Y., Wang, S., & Zhou, M. (2024) · Engineered Regeneration · doi:10.1016/j.engreg.2024.01.002 · Cited by 23
Subcellular Nanobionic Liposome with High Zeta Potential Enhances Intravesical Adhesion and Drug Delivery
Du, H., Yin, H., Qin, Y., Min, Y., Deng, Q., Tan, J., Li, G., Li, N., Zhu, C., & Xu, Y. (2024) · ACS Nano · doi:10.1021/acsnano.3c11235 · Cited by 22
Nanomaterials Enhance Pyroptosis-Based Tumor Immunotherapy
Ji, F., Shi, C., Shu, Z., & Li, Z. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s457309 · Cited by 22
“61 Nanotechnology helps overcome these obstacles, and a wide range of nanoplatforms have been developed and show broad application potential.”
Background
Multifunctional Biomimetic Nanocarriers for Dual‐Targeted Immuno‐Gene Therapy Against Hepatocellular Carcinoma
Sun, Y., Liu, Y., Li, R., Zhang, C., Wu, M., Zhang, X., Zheng, A., Liao, N., Zheng, Y., Xu, H., et al. (2024) · Advanced Science · doi:10.1002/advs.202400951 · Cited by 21
Nanomaterial-assisted delivery of CpG oligodeoxynucleotides for boosting cancer immunotherapy
Zhang, Z., Yu, L., Liu, W., & Huang, Y. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.09.044 · Cited by 21
Bioinspired Suction-Driven Strategies with Nanoscale Skin-Controllable Adhesive Architectures for Efficient Liquid Formulated Transdermal Patches
Lim, D., Song, M., Kim, M., Park, H., Kim, D. W., & Pang, C. (2025) · ACS Nano · doi:10.1021/acsnano.5c00585 · Cited by 23
Current Adenosinergic Therapies: What Do Cancer Cells Stand to Gain and Lose?
Kotulová, J., Hajdúch, M., & Džubák, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212569 · Cited by 21
Designing receptor agonists with enhanced pharmacokinetics by grafting macrocyclic peptides into fragment crystallizable regions
Sakai, K., Sugano-Nakamura, N., Mihara, E., Rojas, N., Watanabe, S., Sato, H., Imamura, R., Voon, D. C., Sakai, I., Yamasaki, C., et al. (2022) · Nature Biomedical Engineering · doi:10.1038/s41551-022-00955-6 · Cited by 23
Semiconducting polymer nanomanipulators for thermal sensitization and metastasis-inhibited synergistic cancer therapy
Wu, M., Qu, R., Li, H., Chen, L., Zhang, X., Yuan, Y., Chen, W., Jiang, X., & Xu, Z. C. (2022) · Nano Today · doi:10.1016/j.nantod.2022.101691 · Cited by 21
Treg-targeted efficient-inducible platform for collagen-induced arthritis treatment
Wang, L. Q., Wang, Y., Liu, C., He, J., He, X., Zhang, X., Zhu, C., Sun, J., Wang, Q., Chen, H., et al. (2023) · Materials Today Bio · doi:10.1016/j.mtbio.2023.100557 · Cited by 23
“Reasonable drug “packing” can not only enhance its pharmacokinetics as well as its solubility and bioavailability, but also reduce side effects by controlling their release speed [16,17].”
Background
Hyaluronan-estradiol nanogels as potential drug carriers to target ER+ breast cancer cell line
Paoletti, L., Zoratto, N., Benvenuto, M., Nardozi, D., Angiolini, V., Mancini, P., Masuelli, L., Bei, R., Frajese, G. V., Matricardi, P., et al. (2023) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2023.120900 · Cited by 22
“Hyaluronic acid (HA) is one of the most investigated polysaccharides in the pharmaceutical field, especially in the development of DDS used in viscosupplementation, ophthalmology, pneumology, rhinology, urology and in anticancer therapy, as well as in cosmetics and aesthetic medicine (Fallacara, Baldini, Manfredini, &…”
Influential
A hybrid nanopharmaceutical for specific-amplifying oxidative stress to initiate a cascade of catalytic therapy for pancreatic cancer
Liu, F., Xiang, Q., Luo, Y., Luo, Y., Luo, W., Xie, Q., Fan, J., Ran, H., Wang, Z., & Sun, Y. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01932-0 · Cited by 21
Bioengineered Smart Nanocarriers for Breast Cancer Treatment: Adorned Carbon-Based Nanocomposites with Silver and Palladium Complexes for Efficient Drug Delivery
Safarkhani, M., Moghaddam, S. S., Taghavimandi, F., Bagherzadeh, M., Fatahi, Y., Park, U., Radmanesh, F., Huh, Y. S., & Rabiee, N. (2023) · ACS Omega · doi:10.1021/acsomega.3c07432 · Cited by 21
“17 Low selectivity in delivery and uncontrollable drug release in rudimentary drug delivery systems led to the development of SDDSs. 14 In the past few years, SDDSs have attracted the most inquiries as chemical deliverers to overcome predicaments, such as low chemotherapeutic loading capacity,…”
Background
Generation of a drug-induced renal injury list to facilitate the development of new approach methodologies for nephrotoxicity
Connor, S., Li, T., Qu, Y., Roberts, R. A., & Tong, W. (2024) · Drug Discovery Today · doi:10.1016/j.drudis.2024.103938 · Cited by 21
Nanoparticle-neutrophils interactions for autoimmune regulation
Kupor, D., Felder, M. L., Kodikalla, S., Chu, X., & Eniola‐Adefeso, O. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115316 · Cited by 23
Nanoformulation-assisted microneedle transdermal drug delivery system: An innovative platform enhancing rheumatoid arthritis treatment
Wendong, Y., Xingxing, Y., Xie, X., Fan, Q., Yujun, S., Shanshan, Z., Shi, Z., & Hairu, X. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117219 · Cited by 23
Ionic Diode‐Based Drug Delivery System
Yoo, H., Kang, S., Kim, J., Cho, W., Ha, H., Oh, S., Jeong, S., Lee, S., Lee, H., Park, C. S., et al. (2024) · Advanced Materials · doi:10.1002/adma.202412377 · Cited by 21
Supramolecular Polymers for Drug Delivery
Zhang, X., Zhuo, J., Wang, D., & Zhu, X. (2025) · Chemistry - A European Journal · doi:10.1002/chem.202404617 · Cited by 21
A narrative review: Ultrasound-Assisted drug delivery: Improving treatments via multiple mechanisms
Tao, W., Lai, Y., Zhou, X., Yang, G., Wu, P., & Yuan, L. (2025) · Ultrasonics · doi:10.1016/j.ultras.2025.107611 · Cited by 20
Dissolving microneedles fabricated from 3D-printed master molds for application in veterinary medicine
Kornicka, J., Śniadek, P., Krzysztof, M., & Rafał, W. (2025) · Scientific Reports · doi:10.1038/s41598-025-98984-z · Cited by 20
Site-specific adaptive nanovesicles for oral insulin delivery
Xia, B., Xu, F., Chen, J., Shan, S., Shen, J., Zhang, Y., Wang, J., Zhou, Z., Sun, W., Jia, Y., et al. (2025) · Science Advances · doi:10.1126/sciadv.ady6386 · Cited by 21
Precision cardiovascular medicine: shifting the innovation paradigm
Aikawa, M., Sonawane, A. R., Chelvanambi, S., Asano, T., Halu, A., Matamalas, J. T., Singh, S. A., Uchida, S., Aïkawa, E., Arenas, À., et al. (2025) · Frontiers in Science · doi:10.3389/fsci.2025.1474469 · Cited by 24
“These novel modalities can also be partnered with a wide array of drug delivery strategies to maximize their effectiveness (337) and reduce off-target effects (338).”
Using tea nanoclusters as β-lactamase inhibitors to cure multidrug-resistant bacterial pneumonia: A promising therapeutic strategy by Chinese materioherbology
Zhou, Z., Li, J., Tan, L., Liu, X., Zheng, Y., Cui, Z., Li, C., Yeung, K., Li, Z., Liang, Y., et al. (2021) · Fundamental Research · doi:10.1016/j.fmre.2021.11.019 · Cited by 20
Therapeutic significance of thymoquinone-loaded chitosan nanoparticles on streptozotocin/nicotinamide-induced diabetic rats: In vitro and in vivo functional analysis
Hosni, A., Abdel‐Moneim, A., Hussien, M., Zanaty, M. I., Eldin, Z. E., & El‐Shahawy, A. A. G. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.09.048 · Cited by 21
Nanomaterial-mediated photoporation for intracellular delivery
Wang, L., Wei, X., Liu, H., & Fan, Y. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.12.050 · Cited by 20
Innovative Delivery and Release Systems for Antioxidants and Other Active Substances in the Treatment of Cancer
Bayındır, Z. S., Losada‐Barreiro, S., Fernández-Bravo, S. E., & Bravo‐Díaz, C. (2023) · Pharmaceuticals · doi:10.3390/ph16071038 · Cited by 20
Nanocarrier‐Based Drug Delivery Systems using Microfluidic‐Assisted Techniques
Alam, M. K. (2023) · Advanced NanoBiomed Research · doi:10.1002/anbr.202300041 · Cited by 21
Overcoming Barriers Associated with Oral Delivery of Differently Sized Fluorescent Core‐Shell Silica Nanoparticles
Erstling, J. A., Bag, N., Gardinier, T. C., Kohle, F. F. E., DomNwachukwu, N., Butler, S. D., Kao, T., Ma, K., Turker, M. Z., Feuer, G. B., et al. (2023) · Advanced Materials · doi:10.1002/adma.202305937 · Cited by 21
Progress in controllable bioorthogonal catalysis for prodrug activation
Liu, X., Huang, T., Chen, Z., & Yang, H. (2023) · Chemical Communications · doi:10.1039/d3cc04286c · Cited by 20
Marine polysaccharides, proteins, lipids, and silica for drug delivery systems: A review
Galasso, C., Ruocco, N., Mutalipassi, M., Barra, L., Costa, V., Giommi, C., Dinoi, A., Genovese, M., Pica, D., Romano, C., et al. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.127145 · Cited by 21
The inherent AIE feature revealed the drug molecular state in cyclodextrin metal–organic framework for enhanced stability and absorption
Peng, Y., Lei, Y., Luo, J., Hu, X., Sun, F., Yang, Y., Guo, M., & Cai, T. (2023) · Chemical Engineering Journal · doi:10.1016/j.cej.2023.147654 · Cited by 20

Authors: Vargason, A. M., Anselmo, A. C., & Mitragotri, S.
Affiliations: University of North Carolina at Chapel Hill (US)
Harvard University (US)
Corresponding author: Mitragotri, Samir
ORCID: Vargason, Ava M.
Anselmo, Aaron C.
Mitragotri, Samir
Venue: Nature Biomedical Engineering
Publisher: Springer Science and Business Media LLC
Published: 2021-04-01
Volume: 5
Issue: 9
Pages: 951-967
ISSN: 2157-846X (ISSN-L)
DOI: 10.1038/s41551-021-00698-w
OpenAlex: W3143156272
Cited by: 1,361
References: 275
Citations by year: 2026: 170 · 2025: 314 · 2024: 366 · 2023: 293 · 2022: 170 · 2021: 48
FWCI: 19.23
Type: journal article
Language: en
Open access: closed
Licence: www.springernature.com/gp/researchers/text-and-data-mining (tdm)
www.springernature.com/gp/researchers/text-and-data-mining (vor)
Locations: Nature Biomedical Engineering (publishedVersion)
PubMed (publishedVersion)
Funders: National Science Foundation (DGE-1650116)
U.S. Department of Health & Human Services | National Institutes of Health (R35GM137898, 1R01HL143806-01)
United States Department of Defense | Defense Threat Reduction Agency (HDTRA1-15-1-0045)
U.S. Department of Defense (W81XWH-19-2-0011)
Topics: Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
Keywords: drug delivery technology, small molecules, macromolecules, nucleic acids, proteins, immunoglobulins, medication adherence
MeSH terms: Pharmaceutical Preparations, Humans, Nucleic Acids, Peptides, Proteins, Drug Delivery Systems

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The evolution of commercial drug delivery technologies

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks